Skip to Content
Merck
CN

DNA adducts of ortho-toluidine in human bladder.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2010-12-02)
Francine Böhm, Dagmar Schmid, Stefan Denzinger, Wolf F Wieland, Elmar Richter
ABSTRACT

4-Aminobiphenyl (4-ABP) and o-toluidine are known human bladder carcinogens, but only 4-ABP-releasing DNA adducts are known. Determination of 4-ABP and o-toluidine-releasing DNA adducts in epithelial and submucosal bladder tissues of sudden death victims (SDV: n=46), and bladder tumours (n=12) by gas chromatography/mass spectrometry. Above background, 4 and 11 of 12 tumour samples contained adducts of 4-ABP (0.057 ± 0.125 fmol/µg DNA) and o-toluidine (8.72 ± 4.49 fmol/µg DNA), respectively. Lower adduct levels were present in both epithelial and submucosal bladder tissues of SDV (4-ABP: 0.011 ± 0.022 and 0.019 ± 0.047 fmol/µg DNA; o-toluidine: 0.24 ± 0.63 and 0.27 ± 0.70 fmol/µg DNA). Detection of o-toluidine-releasing DNA adducts support the carcinogenicity of o-toluidine in the human bladder.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
o-Toluidine solution, 0.6 M in glacial acetic acid, contains thiourea as stabilizer
Sigma-Aldrich
o-Toluidine, ≥99%
Sigma-Aldrich
o-Toluidine, 98%
Sigma-Aldrich
4-Aminobiphenyl, ≥98%
Supelco
4-Aminobiphenyl, analytical standard
Sigma-Aldrich
o-Toluidine, purum p.a., ≥99.5% (GC)